MendelScan Disease Module Expansion
Various Rare Diseases (e.g., Gaucher's, PNH, Neuroendocrine Cancers)
CommercialActive
Key Facts
Indication
Various Rare Diseases (e.g., Gaucher's, PNH, Neuroendocrine Cancers)
Phase
Commercial
Status
Active
Company
About Mendelian
Mendelian is a London-based diagnostics company tackling the significant challenge of delayed rare disease diagnosis. The company's AI-powered software platform, MendelScan, integrates with primary care health record systems to systematically scan for patients whose symptoms match encoded clinical criteria for rare conditions, aiming to reduce misdiagnoses, unnecessary referrals, and healthcare costs. Backed by NHS awards and partnerships, Mendelian operates a B2B business model, selling its software as a medical device to healthcare providers like the NHS to improve care pathways and enable timely specialist referral and genomic testing.
View full company profile